School of Chemistry, Xi'an Key Laboratory of Sustainable Energy Material Chemistry, Xi'an Jiao Tong University, Xi'an 710049, China.
School of Chemistry, Xi'an Key Laboratory of Sustainable Energy Material Chemistry, Xi'an Jiao Tong University, Xi'an 710049, China.
Acta Biomater. 2022 Jul 15;147:245-257. doi: 10.1016/j.actbio.2022.04.034. Epub 2022 Apr 27.
On-demand designed theranostics nanoagents show promising applications for next-generation precision-and-personalized oncotherapy. Researchers have since aimed to develop nanoplatforms that can efficiently deliver drugs and contrast medium to tumor and release active ingredients in response to tumor microenvironment (TME) conditions. Herein, we propose a modular strategy, and develop a series of nanoplatforms based on metal-coordinated-polyprodrugs for cancer theranostics. The polyprodrugs were synthesized through a click-reaction between amino acid and doxorubicin (DOX) with dipropiolate. The backbones of the polyprodrugs had intrinsic sensitivities to pH and/or GSH, and provided abundant -COOH, -NH2, or -S-S- to chelate with functional metal ions and further self-assembled to form different morphologies. Dicysteine, which contains disulfide bond (-S-S-), was chosen to copolymerize with DOX and triethylene glycol dipropiolate (TEP) to prepare the pH/GSH dual-responsive polyprodrug poly(dicysteine-co-TEP-co-DOX) (pDTD), then separately coordinated with Gd3+, Fe3+, and Mn2+ to construct nanoplatforms pDTD@M (M representing the metal ions). In vitro and in vivo investigations suggest the metal-coordinated-polyprodrug nanoplatforms have good magnetic resonance imaging (MRI) ability and efficient tumor-growth inhibition with high safety. The design strategy of nanoplatforms based on metal-coordinated-polyprodrugs provides a new idea for on-demand construction of promising theranostics agents. STATEMENT OF SIGNIFICANCE: Compared to small molecule antitumor drugs, polymeric drugs have high drug loading ratio and are easily enriched at the tumor site to achieve improved therapy efficacy. This work utilizes click reactions to link amino acids with anticancer drugs to produce polymeric drugs that are degraded in response to tumor microenvironment and released small molecule antitumor drugs mainly in tumor sites, and subtly utilizes the coordination of amino acid to chelate MRI functional metal ion to realize enhanced MRI imaging mediated tumor therapy. This strategy provides a new idea for the convenient construction of polymeric drugs for tumor theranostics.
按需设计的治疗纳米制剂在下一代精准和个性化肿瘤治疗中显示出有前景的应用。研究人员一直致力于开发能够将药物和对比剂有效递送到肿瘤部位并根据肿瘤微环境 (TME) 条件释放有效成分的纳米平台。在此,我们提出了一种模块化策略,并开发了一系列基于金属配位聚前药的用于癌症治疗和诊断的纳米平台。聚前药通过氨基酸与阿霉素 (DOX) 与丙二酸盐之间的点击反应合成。聚前药的骨架对 pH 和/或 GSH 具有固有敏感性,并提供丰富的 -COOH、-NH2 或 -S-S-,与功能金属离子螯合,并进一步自组装形成不同的形态。二半胱氨酸含有二硫键 (-S-S-),被选择与 DOX 和三乙二醇丙二酸盐 (TEP) 共聚制备 pH/GSH 双重响应聚前药聚 (二半胱氨酸-co-TEP-co-DOX) (pDTD),然后分别与 Gd3+、Fe3+和 Mn2+配位构建纳米平台 pDTD@M (M 代表金属离子)。体外和体内研究表明,金属配位聚前药纳米平台具有良好的磁共振成像 (MRI) 能力和高效的肿瘤生长抑制作用,且具有很高的安全性。基于金属配位聚前药的纳米平台的设计策略为按需构建有前途的治疗诊断剂提供了新的思路。